Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bioactive PI3-kinase/Akt/mTOR Inhibitors in Targeted Lung Cancer Therapy
Somayyeh Ghareghomi, Vahideh Atabaki, Naseh Abdollahzadeh, et al.
Advanced Pharmaceutical Bulletin (2021)
Open Access | Times Cited: 10

Showing 10 citing articles:

Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications
Ying Liu, Wei‐Qun Ding, Jianxun Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 42
About a Possible Impact of Endodontic Infections by Fusobacterium nucleatum or Porphyromonas gingivalis on Oral Carcinogenesis: A Literature Overview
Luca Ciani, Antonio Libonati, Maria Dri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5083-5083
Open Access | Times Cited: 8
Molecular mechanism of genetic, epigenetic, and metabolic alteration in lung cancer
Shahab Fatima, Vineet Kumar, Dhruv Kumar
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access
Effects of Angiogenic Factors on the Epithelial-to-Mesenchymal Transition and Their Impact on the Onset and Progression of Oral Squamous Cell Carcinoma: An Overview
Silvia Pomella, Ombretta Melaiu, Maria Dri, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1294-1294
Open Access | Times Cited: 2
Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti-Breast Cancer Therapy
Yaseen Hussain, Haroon Khan, Waqas Alam, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 9
[S100A10 promotes proliferation and invasion of lung adenocarcinoma cells by activating the Akt-mTOR signaling pathway].
Hong Wang, Zhou Sun, Weihong Zhao, et al.
PubMed (2023) Vol. 43, Iss. 5, pp. 733-740
Closed Access | Times Cited: 2
SNAI1 as a Biomarker for Prognostic Prediction and Targeted Therapy in Lung Squamous Cell Carcinoma
Beibei Li, Rongkai Li
Research Square (Research Square) (2024)
Open Access
Exploiting new strategies in combating head and neck carcinoma: A comprehensive review on phytochemical approaches passing through PI3K/Akt/mTOR signaling pathway
Amin Iranpanah, Mohammad Bagher Majnooni, Hossein Biganeh, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 7, pp. 3736-3762
Closed Access
Interplay of Nano-based Delivery Systems and Protein Signalling in Ameliorating Lung Diseases
Mangesh Pradeep Kulkarni, Keshav Raj Paudel, Ayeh Bani Saeid, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106432-106432
Open Access
Targeting PI3K/AKT/mTOR Signalling pathway in non-small-cell lung carcinoma: Exploring promising bioactive natural compounds as anti-cancer agents
Anam.N. Khan, Rahul D. Jawarkar, Magdi E. A. Zaki, et al.
Chemical Physics Impact (2024), pp. 100793-100793
Open Access
Page 1

Scroll to top